Acropolis Investment Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-344
Closed -$158K – 290
2023
Q4
$158K Hold
344
– – 0.01% 238
2023
Q3
$167K Sell
344
-2
-0.6% -$940 0.01% 225
2023
Q2
$155K Hold
346
– – 0.01% 220
2023
Q1
$168K Hold
346
– – 0.01% 210
2022
Q4
$177K Buy
346
+2
+0.6% +$1.05K 0.02% 197
2022
Q3
$167K Sell
344
-60
-15% -$29.2K 0.02% 191
2022
Q2
$189K Hold
404
– – 0.02% 183
2022
Q1
$176K Hold
404
– – 0.02% 192
2021
Q4
$187K Hold
404
– – 0.02% 194
2021
Q3
$157K Hold
404
– – 0.02% 194
2021
Q2
$179K Hold
404
– – 0.02% 187
2021
Q1
$169K Buy
404
+2
+0.5% +$798 0.02% 189
2020
Q4
$165K Hold
402
– – 0.02% 182
2020
Q3
$166K Hold
402
– – 0.02% 171
2020
Q2
$156K Buy
402
+1
+0.2% +$374 0.02% 163
2020
Q1
$126K Buy
+401
New +$135K 0.02% 164

Other funds holding HUM

Acropolis Investment Management's HUM Position: Q1 2024 in Review

Acropolis Investment Management sold out of Humana (HUM) in Q1 2024, closing a stake of 344 shares — an estimated $158K sold.

Acropolis Investment Management first reported a position in HUM in Q1 2020 and held it in 16 quarters. The position peaked at $189K in Q2 2022. 1,031 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Acropolis Investment Management reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Acropolis Investment Management sold 344 Humana shares in Q1 2024, an estimated $158K.
  • Acropolis Investment Management first reported a position in Humana in Q1 2020 and held it in 16 quarters.
  • Acropolis Investment Management's Humana position peaked at $189K in Q2 2022.
  • 1,031 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Acropolis Investment Management's 13F filing for Q1 2024, filed 17 Apr 2024.